Impact of Olmesartan Medoxomil on Amiodarone‐Induced Pulmonary Toxicity in Rats: Focus on Transforming Growth Factor‐ß1

AAI Sharaf El‐Din, OM Abd Allah - Basic & clinical …, 2016 - Wiley Online Library
Amiodarone (AD) is one of the most frequently prescribed anti‐arrhythmic agents worldwide,
but its effectiveness is limited due to the development of pulmonary toxicity. Several lines of …

Impact of Olmesartan Medoxomil on Amiodarone-Induced Pulmonary Toxicity in Rats: Focus on Transforming Growth Factor-ß1

AAIS El-Din, OM Abd Allah - Basic & clinical …, 2016 - pubmed.ncbi.nlm.nih.gov
Amiodarone (AD) is one of the most frequently prescribed anti-arrhythmic agents worldwide,
but its effectiveness is limited due to the development of pulmonary toxicity. Several lines of …

Impact of Olmesartan Medoxomil on Amiodarone‐Induced Pulmonary Toxicity in Rats: Focus on Transforming Growth Factor‐ß1

AAIS El‐Din, OM Abd Allah - Basic & Clinical Pharmacology & Toxicology, 2016 - infona.pl
Amiodarone (AD) is one of the most frequently prescribed anti‐arrhythmic agents worldwide,
but its effectiveness is limited due to the development of pulmonary toxicity. Several lines of …

Impact of Olmesartan Medoxomil on Amiodarone-Induced Pulmonary Toxicity in Rats: Focus on Transforming Growth Factor-ß1.

AAI Sharaf El‐Din… - Basic & Clinical …, 2016 - search.ebscohost.com
Amiodarone (AD) is one of the most frequently prescribed anti-arrhythmic agents worldwide,
but its effectiveness is limited due to the development of pulmonary toxicity. Several lines of …

Impact of Olmesartan Medoxomil on Amiodarone-Induced Pulmonary Toxicity in Rats: Focus on Transforming Growth Factor-ß1.

SED AA, OM Abd Allah - Basic & Clinical Pharmacology & …, 2016 - europepmc.org
Amiodarone (AD) is one of the most frequently prescribed anti-arrhythmic agents worldwide,
but its effectiveness is limited due to the development of pulmonary toxicity. Several lines of …